Bioanalytical Systems Inc: (NASD: BASI)
$1.45
-0.03 (-2.03%)
Volume 32,520
May 21 03:18 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 1.41 - 1.49 |
| 52wk Low - High | 0.81 - 1.84 |
| Previous Close | 1.48 |
| Avg. Volume | 9,436 |
| Industry | MED INSTRUMENTS |
| Market Cap | 11.33 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 1.76 |
| PE (Forward) | 37.00 |
| Current Year Est. | 0.04 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
 3 |
Zacks Recommendation
|
No Zacks Recommendation |
Zacks Industry Rank
|
114 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 37.00 |
| PEG Ratio | NA |
| Current Year Est. | 0.04 |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 08-13-2013 |
| EPS Last Year | -0.11 |
| Expected Earnings Growth | NA |
Company Description
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either in-house or at the company.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (ND) |
Next Qtr (ND) |
Current Year (ND) |
Next Year (ND) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | NA | NA |
| Number of Estimates | NA | NA | NA | NA |
| Low Estimate | NA | NA | NA | NA |
| High Estimate | NA | NA | NA | NA |
| Year Ago EPS | NA | NA | NA | NA |
| EPS Growth | NA | NA | NA | NA |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| BIOANALYTIC SYS | BASI | 1.48 | |
|
| NATUS MEDICAL | BABY | 14.24 | |
|
| CRYOLIFE INC | CRY | 6.42 | |
|
| DELCATH SYS INC | DCTH | 0.44 | |
|
| GLOBUS MEDICAL | GMED | 15.90 | |
|
| HEARTWARE INTL | HTWR | 97.45 | |
|
| INTUITIVE SURG | ISRG | 479.42 | |
|
| MELA SCIENCES | MELA | 1.08 | |
|
| OXYSURE SYSTEMS | OXYS | 0.86 | |
|
| PACIFIC BIOSCI | PACB | 2.50 | |
|
Sector:Medical>> Industry:MED INSTRUMENTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
Zacks Rank #1 Addition for Thursday
Apr 18, 2013
BASi Introduces Culex NxT
Jan 03, 2013
Zacks #1 Rank Additions for Monday
Dec 31, 2012
Zacks #1 Rank Additions for Wednesday
Dec 26, 2012
Zacks #1 Rank Additions for Thursday
Dec 20, 2012
Zacks #1 Rank Additions for Thursday
Dec 13, 2012
Zacks #1 Rank Additions for Tuesday
Dec 11, 2012
Zacks #1 Rank Additions for Friday
Nov 30, 2012
Financials
| EPS TTM | -0.11 |
| Sales | 28 |
| Net Income | -3 |
| Price/Earnings | NA |
| Price/Book | 1.34 |
| Price/Cash Flow | NA |
| Price/Sales | 0.46 |
News
Stocks Hitting 52-Week Highs - Benzinga
Jan 15, 2013
Bioanalytical Systems Inc. Reports Operating Results (10-K) - GuruFocus
Dec 31, 2012
Morning Market Losers - Benzinga
Dec 27, 2012
Bioanalytical Systems Inc. Reports Operating Results (10-Q) - GuruFocus
Aug 14, 2012
Jacqueline Lemke Named Interim President & CEO of Bioanalytical Systems - Benzinga
Jul 6, 2012
UPDATE: Ladenburg Thalmann Reduces PT on Bioanalytical Systems to $2.25 - Benzinga
May 15, 2012
Bioanalytical Systems Inc. Reports Operating Results (10-Q) - GuruFocus
May 14, 2012
BASi Names New CFO - Benzinga
Apr 5, 2012
Broker Recommendations
| Current ABR | 1.00 |
| ABR (Last Week) | 1.00 |
| # of recs in ABR | 1 |
| Average Target Price | 2.15 |
| Industry Rank by ABR | 114 out of 265 |
| Rank in Industry | 11 out of 52 |
